ASCO Interview 2013: Dr Brian Healey Bird explains all about targeted therapies in Lymphoma
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
Dr Brian Healey Bird FCPI. Consultant Medical Oncologist, Bon Secours Cork. Senior Clinical Lecturer, University College Cork.
A review of the presentation by Jaume Capdevila, Barcelona Spain. Unfortunately Neuroendocrine tumours (NETs) are often advanced at the time of diagnosis and the 5 year survival ranges… read more.
Poster 67 Elizabeth Goode elizabeth.goode@nnuh.nhs.uk. Chemotherapy is an independent risk factor for thromboembolism (TE), although current guidelines do not recommend routine use of anti-thrombin agents in this setting.
FDA Highlights by Bruce Sylvester – Lexapro (escitalopram), which is used to treat depression and anxiety, appears to improve a stress-related heart condition in persons with stable coronary… read more.
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.
Trend toward more cancers and more deaths among heart failure patients. Heart failure patients are surviving more often with the heart condition but they are increasingly more likely… read more.
In recent years, there has been an adjustment in the scientific thinking about the utility of screening men for prostate cancer using prostate-specific antigen (PSA).
by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.
CHICAGO – Five pivotal studies were released today ahead of the plenary session of the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.